Has Sydney Holland received payments from drug or device companies?

Yes. Drug and device makers reported $2,053 in general payments to Sydney Holland across 172 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sydney Holland did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sydney Holland come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sydney Holland

Physician Assistant · Clearwater, KSNPI 1871043935

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 172 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 21.4% — the pattern of someone who eats at a lot of different presentations. 2023 is the largest year on record at $977, 3.6 times the $273 reported in 2021.

$2,053in general payments, 2019–2025

Across 172 payments — averaging $11.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Lilly USA, LLC$440
AbbVie$381
Novo Nordisk$228
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$130
AstraZeneca$115
Idorsia Pharmaceuticals US Inc$110
plus $649 from 24 others

What the payments were for

Food & beverage$2,053100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Lilly USA, LLC	38	$440
AbbVie	50	$381
Novo Nordisk	20	$228
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	8	$130
AstraZeneca	8	$115
Idorsia Pharmaceuticals US Inc	7	$110
Otsuka America Pharmaceutical, Inc.	5	$76
Sanofi-aventis U.S. LLC	4	$70
Johnson & Johnson	3	$51
Merck	3	$50
Biohaven Pharmaceutical Holding Company Ltd.	3	$40
Boehringer Ingelheim	2	$39
GSK	2	$29
Amgen	2	$28
Astellas Pharma US Inc	2	$27
Amarin Pharma, Inc.	1	$25
Supernus Pharmaceuticals, Inc.	1	$23
Sumitomo Pharma America, Inc.	1	$18
Sunovion Pharmaceuticals Inc.	1	$18
Genentech USA, Inc.	1	$17
Dexcom, Inc.	1	$16
Radius Health, Inc.	1	$16
Daiichi Sankyo Inc.	1	$16
Nevro Corp.	1	$14
Axsome Therapeutics, Inc.	1	$14
Teva Pharmaceuticals USA, Inc.	1	$13
Pfizer	1	$13
Xeris Pharmaceuticals, Inc.	1	$12
Neos Therapeutics, LP	1	$12
Bayer	1	$12

How this compares

$2,053 in reported general payments places this provider in the 80th percentile of 1,016 physician assistant providers in Kansas.

See all physician assistant providers in Kansas →

Other physician assistant in Clearwater

Sierra FergusonWichita$25K
Dylan TimmermannTopeka$19K
Heather HowellKansas City$16K
Amy BrettmanShawnee$14K
Ashton YoungersWichita$14K
Anthony GunawanLakin$13K
Therese SchrandtWichita$13K
Mike HallWichita$13K
Melissa WilkesFort Riley$13K
Jenny MartensWichita$13K

See the full list for Kansas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →